Addeo A - Search Results

1

Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary.

Fusco V, Santini D, Campisi G, Bertoldo F, Lanzetta G, Ibrahim T, Bertetto O, Numico G, Addeo A, Berruti A, Bettini G, Saia G, Bedogni A. Fusco V, et al. Among authors: addeo a. JCO Oncol Pract. 2020 Mar;16(3):142-145. doi: 10.1200/JOP.19.00645. Epub 2020 Jan 24. JCO Oncol Pract. 2020. PMID: 32048935 No abstract available.

2

A phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbine.

Dongiovanni V, Addeo A, Berruti A, Buffoni L, Dongiovanni D, Polimeni MA, Fissore C, Barone C, Bertetto O. Dongiovanni V, et al. Among authors: addeo a. Anticancer Res. 2004 Jul-Aug;24(4):2567-72. Anticancer Res. 2004. PMID: 15330216 Free article. Clinical Trial.

3

Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II study.

Dongiovanni D, Fissore C, Berruti A, Buffoni L, Addeo A, Barone C, Polimeni MA, Ottaviani D, Bertetto O, Dongiovanni V. Dongiovanni D, et al. Among authors: addeo a. Lung Cancer. 2005 Feb;47(2):269-75. doi: 10.1016/j.lungcan.2004.06.019. Lung Cancer. 2005. PMID: 15639726 Clinical Trial.

4

Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial.

Dongiovanni V, Buffoni L, Berruti A, Dongiovanni D, Grillo R, Barone C, Addeo A, Fissore C, Bertetto O. Dongiovanni V, et al. Among authors: addeo a. Cancer Chemother Pharmacol. 2006 Aug;58(2):203-9. doi: 10.1007/s00280-005-0157-6. Epub 2005 Dec 6. Cancer Chemother Pharmacol. 2006. PMID: 16331497 Clinical Trial.

5

Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study?

Fusco V, Bedogni A, Addeo A, Campisi G. Fusco V, et al. Among authors: addeo a. Support Care Cancer. 2017 Feb;25(2):345-349. doi: 10.1007/s00520-016-3147-9. Epub 2016 Mar 9. Support Care Cancer. 2017. PMID: 26961666 No abstract available.

6

Is CBOP/BEP an alternative to BEP for patients with poor prognosis metastatic germ cell tumours?

Addeo A, Fusco V, Braybrooke JP. Addeo A, et al. ESMO Open. 2016 Aug 25;1(4):e000089. doi: 10.1136/esmoopen-2016-000089. eCollection 2016. ESMO Open. 2016. PMID: 27843634 Free PMC article. No abstract available.

7

Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune response.

Carbone A, Rodeck U, Mauri FA, Sozzi M, Gaspari F, Smirne C, Prati A, Addeo A, Novarino A, Robecchi A, Bertetto O, Emanuelli G, Bellone G. Carbone A, et al. Among authors: addeo a. Cancer Biol Ther. 2005 Feb;4(2):231-41. doi: 10.4161/cbt.4.2.1476. Epub 2005 Feb 2. Cancer Biol Ther. 2005. PMID: 15684607

8

Circulating vascular endothelial growth factor and interferon-gamma-inducible protein-10 levels in pancreatic cancer during chemotherapy.

Bellone G, Novarino A, Chiappino I, Gramigni C, Carbone A, Addeo A, Tonel E, Bertetto O, Emanuelli G. Bellone G, et al. Among authors: addeo a. Anticancer Res. 2005 Sep-Oct;25(5):3287-91. Anticancer Res. 2005. PMID: 16101140 Free article. Clinical Trial.

9

Activity of weekly paclitaxel in advanced hormone-refractory prostate cancer.

Chiappino I, Destefanis P, Addeo A, Galetto A, Cucchiarale G, Munoz F, Zitella A, Ferrando U, Fontana D, Ricardi U, Tizzani A, Bertetto O. Chiappino I, et al. Among authors: addeo a. Am J Clin Oncol. 2007 Jun;30(3):234-8. doi: 10.1097/01.coc.0000256706.16313.49. Am J Clin Oncol. 2007. PMID: 17551298 Clinical Trial.

10

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status.

Cortellini A, Giusti R, Filetti M, Citarella F, Adamo V, Santini D, Buti S, Nigro O, Cantini L, Di Maio M, Aerts JGJV, Bria E, Bertolini F, Ferrara MG, Ghidini M, Grossi F, Guida A, Berardi R, Morabito A, Genova C, Mazzoni F, Antonuzzo L, Gelibter A, Marchetti P, Chiari R, Macerelli M, Rastelli F, Della Gravara L, Gori S, Tuzi A, De Tursi M, Di Marino P, Mansueto G, Pecci F, Zoratto F, Ricciardi S, Migliorino MR, Passiglia F, Metro G, Spinelli GP, Banna GL, Friedlaender A, Addeo A, Ficorella C, Porzio G, Tiseo M, Russano M, Russo A, Pinato DJ. Cortellini A, et al. Among authors: addeo a. J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2. J Hematol Oncol. 2022. PMID: 35062993 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page